Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definition
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Cell therapy technologies market, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Process trends
2.1.4 Cell type trends
2.1.5 End user trends
2.1.6 Regional trends
Chapter 3 Cell Therapy Technologies Market Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of chronic diseases
3.3.1.2 Increased government investments
3.3.1.3 Increasing GMP licenses for cell therapy production
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of cell therapies
3.3.2.2 Shortage of trained professionals
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By process
3.4.3 By cell type
3.4.4 By end user
3.5 COVID-19 impact analysis
3.6 Cell therapy technologies framework
3.7 Technology landscape
3.8 Porter’s analysis
3.8.1 Industry rivalry
3.8.2 Buyer power
3.8.3 Supplier power
3.8.4 Threat of substitute
3.8.5 Threat of new entrants
3.9 PESTEL analysis
3.9.1 Political
3.9.2 Economical
3.9.3 Social
3.9.4 Technological
3.9.5 Environmental
3.9.6 Legal
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic dashboard
Chapter 5 Cell Therapy Technologies Market, By Product
5.1 Key segment trends
5.2 Sera, media, reagent
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Cell engineering product
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Cell culture vessels
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Equipment
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.2 Cell processing equipment
5.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.3 Single use equipment
5.5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.4 Others
5.5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Systems and software
5.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Others
5.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Cell Therapy Technologies Market, By Process
6.1 Key segment trends
6.2 Cell processing
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Cell preservation distribution and handling
6.3.1.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Process monitoring and quality control
6.4.1.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Cell Therapy Technologies Market, By Cell Type
7.1 Key segment trends
7.2 T cell
7.2.1.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Stem cell
7.3.1.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Others
7.4.1.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Cell Therapy Technologies Market, By End User
8.1 Key segment trends
8.2 Biotechnology and biopharmaceutical
8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 CRO and CMO
8.3.1 Market size, by region, 2018 - 2032 (USD Million)
8.4 Cell bank and research institutes
8.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 Cell Therapy Technologies Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 Spain
9.3.5 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of MEA
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific Inc.
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Product landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 Merck KGaA
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 Danaher Corporation
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 Strategic outlook
10.3.5 SWOT analysis
10.4 Sartorius AG
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 FUJIFILM Irvine Scientific, Inc.
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Lonza Group AG
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 Becton Dickinson and Company
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 GE Healthcare
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 Strategic outlook
10.8.5 SWOT analysis
10.9 Terumo BCT
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 Strategic outlook
10.9.5 SWOT analysis
10.10 Avantor, Inc.
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 Bio-Techne Corporation
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Corning Incorporated
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 Strategic outlook
10.12.5 SWOT analysis
